BD² creates an open‑science network that integrates genetic, biological, and clinical data from researchers, clinicians, and participants to accelerate bipolar disorder discovery and improve patient care. By linking a longitudinal cohort of over 4,000 individuals with bipolar I to a collaborative platform of 350+ scientists, the organization enables real‑time data sharing and analysis, shortening the gap between scientific breakthroughs and evidence‑based treatments.
Funding
Funding not disclosed
Founders
Product
Problem
People with bipolar disorder often experience long delays in accurate diagnosis and limited access to personalized, evidence‑based treatments, while researchers lack integrated, large‑scale datasets that combine genetic, biological, and clinical information.
Solution
BD² creates an open‑science collaborative network that links clinicians, researchers, and individuals with bipolar disorder to share and analyze combined genetic, omics, and longitudinal clinical data. By aggregating data from over 4,000 participants and more than 350 scientific and clinical partners, the platform enables large‑scale discovery of biomarkers and genetic mechanisms underlying the disorder. Integrated data pipelines support hypothesis‑driven research, while cloud‑based analytics and the Brain Omics Platform provide multi‑modal insights into brain tissue signatures. The network also connects real‑world clinical care with research cohorts, allowing findings to be rapidly translated into diagnostic tools and personalized treatment strategies. Open data releases and standardized APIs encourage broader community participation and accelerate the translation of scientific breakthroughs into improved patient outcomes.
Target Audience
Primary users are academic researchers, clinicians, and pharmaceutical scientists studying bipolar disorder, as well as individuals with bipolar disorder who contribute data to the longitudinal cohort.
Features
- Secure, consent‑driven data repository combining genomics, epigenomics, transcriptomics, proteomics, and longitudinal clinical records
- Integrated network linking major academic medical centers, biobanks, and patient advocacy groups for coordinated data collection and sharing
- Cloud‑based analytics platform with standardized pipelines for multi‑omics integration and biomarker discovery
- Open‑science data release framework providing downloadable datasets and API access for external researchers
- Longitudinal cohort study design enabling tracking of disease progression, treatment response, and comorbidities over time
- Collaborative grant and project management tools to coordinate multi‑institutional research initiatives